| Identification | Back Directory | [Name]
Ozagrel sodium | [CAS]
189224-26-8 | [Synonyms]
Xanbo
D01684
Ozapen
KCT-0809
Athrombone
Ozagrel Na
Ozapen (tn)
OZAGREL SODIUM
Ozagrel Impurity 45
Ozagrel sodium (jan)
Ozagrel sodium USP/EP/BP
(130952-46-4) ozagrel sodium
OZAGREL SODIUM (OKY-046 SODIUM)
sodium (E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate
(E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]acrylic acid sodium salt
(2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic acid sodium salt
2-Propenoic acid,3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt (1:1), (2E)- | [EINECS(EC#)]
1806241-263-5 | [Molecular Formula]
C13H11N2NaO2 | [MOL File]
189224-26-8.mol | [Molecular Weight]
250.23 |
| Hazard Information | Back Directory | [Chemical Properties]
White powder | [Uses]
Ozagrel sodium (OKY-046 sodium) is a thromboxane A2 (TXA2) synthase inhibitor. Ozagrel sodium is an antiplatelet agent, which selectively inhibits human platelet aggregation with an IC50 of 53.12 μM[1]. | [IC 50]
TXA2 | [References]
[1] Max Seidy Saito, et al. Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization. J Enzyme Inhib Med Chem. 2016 Dec;31(6):1591-601. DOI:10.3109/14756366.2016.1158712 |
|
|